News on access to niraparib from second line of treatment
Initial decision announced to make niraparib available from second line of treatment only to people with a BRCA1 or BRCA2 mutation.
News
Read our latest updates from research breakthroughs to government actions to fundraising heroes.
Claudia Winkleman presents our BBC Lifeline Appeal
Your donations will be matched pound for pound, up to £30,000!
Breaking down barriers to early diagnosis
We’re ending the postcode lottery in early diagnosis of ovarian cancer.
NHSE ovarian cancer audit announced
We welcome NHS England's landmark announcement to fund an ovarian cancer audit.
Volunteers' Week 2021: a big thank you!
Our volunteers have been spreading the word, sharing stories and campaigning to raise awareness for Target Ovarian Cancer.
Ovarian Cancer Screening study results published
Research into screening for women with no symptoms of ovarian cancer concludes programme would not save lives.
Breakthrough in ovarian cancer treatment with niraparib
Gamechanging drug could benefit thousands of women with advanced ovarian cancer every year.
Research is back: our call for new projects
Our gold-standard ovarian cancer research grants programme is open for 2021.
Dr Alison Wint shares advice for awareness and self-advocacy
For Ovarian Cancer Awareness Month, Dr Alison Wint looks at why awareness and being involved in healthcare decisions is important.
Pioneering drug combination made available
New combination of olaparib and bevacizumab means a leap forward in personalised treatments.
Bloating: urgent ovarian cancer symptom ignored in lockdown
We're urging women to take this key symptom seriously and go to the GP if they’re worried.
One donation, twice the impact with The Big Give
Double up to speed up early diagnosis with The Big Give Christmas Challenge 2020.
